E
Elbert D. Glover
Researcher at University of Maryland, College Park
Publications - 78
Citations - 3712
Elbert D. Glover is an academic researcher from University of Maryland, College Park. The author has contributed to research in topics: Smokeless tobacco & Smoking cessation. The author has an hindex of 25, co-authored 78 publications receiving 3514 citations. Previous affiliations of Elbert D. Glover include University of Kansas & Pennsylvania State University.
Papers
More filters
Journal ArticleDOI
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Richard D. Hurt,David P.L. Sachs,Elbert D. Glover,Kenneth P. Offord,J. A. Johnston,Lowell C. Dale,M. A. Khayrallah,Darrell R. Schroeder,Penny N. Glover,C. R. Sullivan,Ivana T. Croghan,P. M. Sullivan +11 more
TL;DR: A double-blind, placebo-controlled trial of a sustained-release form of bupropion for smoking cessation, which excluded smokers with current depression, but not those with a history of major depression.
Journal ArticleDOI
Transdermal Nicotine for Smoking Cessation: Six-Month Results From Two Multicenter Controlled Clinical Trials
Arden G. Christen,Beiswanger Bb,Mau Ms,Cheryl K. Walker,Dorothy K. Hatsukami,Sharon S Allen,Marguerite Huber,Joni Jensen,Stephen I. Rennard,David M. Daughton,Ronald Cheney,Kathleen Hatlelid,Austin B. Thompson,Edward Lichtenstein,Anthony Biglan,Linda Ochs,Scott A. Heatley,Lawrence H. Repsher,William Schones,Dara Stlllman,Cheryl Casey,Bonnie Poole,Jennifer Leitch,Stephen P. Fortmann,Joel D. Killen,Mark Hansen,L. Rasenick Douss,John S. Hughes,William A. Valliere,Laura J. Solomon,William C. Wadland,Elbert D. Glover,Penny N. Glover,Donna Causey,Mark Knowles,Katherine Voss-Roberts,Della A. Prather,Nancy Trunnell,Diane Moos,Clyde N. Rolf,Robert T. Nowak,Phillip B. Ackerman,Neil Malone +42 more
TL;DR: All transdermal nicotine doses significantly decreased the severity of nicotine withdrawal symptoms and significantly reduced cigarette use by patients who did not stop smoking.
Journal ArticleDOI
Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.
Kara E. Hayford,Christi A. Patten,Teresa A. Rummans,Darrell R. Schroeder,Kenneth P. Offord,Ivana T. Croghan,Elbert D. Glover,David P.L. Sachs,Richard D. Hurt +8 more
TL;DR: Bupropion is efficacious for smoking cessation independently of a former history of major depression or alcoholism, and increases in depressive symptoms during an initial period of abstinence are associated with a return to smoking.
Journal ArticleDOI
Bupropion for Smoking Cessation : Predictors of Successful Outcome
Lowell C. Dale,Elbert D. Glover,David P.L. Sachs,Darrell R. Schroeder,Kenneth P. Offord,Ivana T. Croghan,Richard D. Hurt +6 more
TL;DR: Lower smoking rate, brief periods, or long periods of abstinence with previous attempts to stop smoking, and male gender were predictive of better outcomes, independent of the dose of bupropion that was used.
Journal ArticleDOI
Immunogenicity and Smoking Cessation Outcomes for a Novel Nicotine Immunotherapeutic
Dorothy K. Hatsukami,Douglas E. Jorenby,David Gonzales,Nancy A. Rigotti,Elbert D. Glover,Cheryl Oncken,Donald P. Tashkin,Victor I. Reus,Roxanne C. Akhavain,Raafat E F Fahim,Paul D. Kessler,Minoo Niknian,Matthew W Kalnik,Stephen I. Rennard +13 more
TL;DR: It is demonstrated, as proof of concept, that 3′AmNic‐rEPA elicits Abs to nicotine and is associated with higher continuous abstinence rates (CAR) and its further development as a treatment for nicotine dependence is justified.